ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 156 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $196,147 | -32.1% | 7,677 | -23.8% | 0.28% | -15.0% |
Q2 2023 | $289,008 | -2.9% | 10,077 | -18.8% | 0.33% | -6.1% |
Q1 2023 | $297,492 | +20.8% | 12,411 | -14.5% | 0.35% | +15.7% |
Q4 2022 | $246,276 | -20.6% | 14,521 | -30.6% | 0.30% | -11.0% |
Q3 2022 | $310,000 | -5.8% | 20,916 | +0.2% | 0.34% | +1.5% |
Q2 2022 | $329,000 | -51.0% | 20,875 | -16.2% | 0.33% | -18.8% |
Q1 2022 | $672,000 | -40.1% | 24,915 | -17.8% | 0.41% | -18.4% |
Q4 2021 | $1,122,000 | -58.2% | 30,321 | -46.0% | 0.50% | -48.6% |
Q3 2021 | $2,683,000 | +55.4% | 56,155 | +10.1% | 0.98% | +71.4% |
Q2 2021 | $1,726,000 | +67.1% | 51,000 | +104.0% | 0.57% | +42.2% |
Q1 2021 | $1,033,000 | +56.8% | 25,000 | +64.5% | 0.40% | -19.8% |
Q4 2020 | $659,000 | – | 15,200 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |